Progesterone, Micronised

Progesterone, Micronised is a hormone medication being studied in clinical trials for its potential to improve outcomes in various fertility treatments. These trials aim to determine the effectiveness and safety of different formulations and dosages of progesterone in supporting pregnancy and live birth rates for couples struggling with infertility. The studies focus on its use in treatments such as intrauterine insemination (IUI), in vitro fertilization (IVF), and frozen embryo transfer (FET).

Table of Contents

What is Micronized Progesterone?

Micronized progesterone is a form of the hormone progesterone that has been processed to create very small particles. This micronization process makes the hormone easier for your body to absorb and use[1]. Progesterone is a naturally occurring hormone in the female body, playing a crucial role in the menstrual cycle and maintaining pregnancy.

Medical Uses

Micronized progesterone is primarily used in the field of reproductive medicine. Its main applications include:

  • Assisted Reproductive Technology (ART): It’s used to support the luteal phase (the period after ovulation) during fertility treatments[1].
  • Intrauterine Insemination (IUI): Some studies are investigating its use in IUI treatments[1].
  • In Vitro Fertilization (IVF): It’s commonly used in IVF procedures, particularly in frozen embryo transfer cycles[2].
  • Unexplained Infertility: Research is being conducted on its potential benefits for couples with unexplained infertility[1].

Administration

Micronized progesterone can be administered in different ways:

  • Vaginal Use: The most common form is vaginal capsules or gel. This method allows for direct absorption by the uterus[1][2].
  • Oral Use: In some cases, it may be taken orally, although this is less common in fertility treatments[2].

The dosage and duration of treatment can vary depending on the specific medical condition and treatment protocol. For example, in some IVF protocols, patients might use 200mg three times daily or 400mg twice daily[2].

Effectiveness

The effectiveness of micronized progesterone in fertility treatments is an active area of research. Some key points include:

  • In IVF treatments, progesterone supplementation is considered standard care and has been shown to improve pregnancy outcomes[1].
  • For IUI treatments, research is ongoing to determine if progesterone supplementation can increase live birth rates[1].
  • In frozen embryo transfer cycles, progesterone is crucial for preparing the uterus for embryo implantation[2].

Side Effects and Safety

Micronized progesterone is generally considered safe for use in fertility treatments. However, like all medications, it can have side effects. Common side effects may include:

  • Drowsiness
  • Dizziness
  • Abdominal pain
  • Nausea
  • Breast tenderness

It’s important to note that extensive safety data is available from its use in IVF treatments. Both short-term and long-term assessments of offspring health have not revealed any significant risks associated with progesterone use in reproductive medicine[1].

Ongoing Research

Several clinical trials are currently underway to further investigate the use of micronized progesterone in various fertility treatments:

  • The LUMO study is examining whether progesterone support can improve live birth rates in couples undergoing IUI with mild ovarian stimulation[1].
  • Another study is comparing different formulations and dosages of vaginal micronized progesterone in frozen embryo transfer cycles[2].
  • Researchers are also investigating the impact of progesterone levels on pregnancy outcomes in frozen embryo transfer cycles[2].

These ongoing studies aim to optimize the use of micronized progesterone in various fertility treatments, potentially improving success rates and patient outcomes.

Aspect Details
Drug Name Progesterone, Micronised
Main Uses in Trials Luteal phase support in IUI, IVF, and FET treatments
Administration Vaginal capsules (various dosages)
Primary Outcomes Live birth rates, ongoing pregnancy rates
Secondary Outcomes Embryo quality, implantation rates, clinical pregnancy rates
Target Population Women with unexplained infertility or undergoing fertility treatments
Safety Assessment Side effects, pregnancy complications, neonatal outcomes
Additional Measures Cost-effectiveness, quality of life impact

Ongoing Clinical Trials on Progesterone, Micronised

  • Study on the Effects of Estradiol, Progesterone, and Online Sleep Therapy for Insomnia and Menopausal Symptoms in Perimenopausal Women

    Recruiting

    3 1 1 1
    Investigated diseases:
    The Netherlands
  • Study on the Effectiveness of Vaginal Micronized Progesterone for Infertility in Patients Undergoing Assisted Conception with Frozen Embryo Transfer (AC-FET)

    Recruiting

    3 1 1 1
    Investigated diseases:
    Spain
  • Study on the Safety of Micronized Progesterone and Norethisterone Acetate with Estradiol for Menopausal Symptoms in Women

    Not yet recruiting

    3 1 1
    Sweden
  • Study on Subfertility: Comparing Estradiol Valerate and Micronised Progesterone for Frozen-Thawed Embryo Transfer in Women Seeking Pregnancy

    Not recruiting

    3 1 1 1
    Belgium
  • Study on the Effect of Ovarian Stimulation Intensity Using Clomifene Citrate and Follitropin Alfa in Women with Infertility and Suboptimal Response

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Spain
  • Study on Progesterone for Improving Birth Rates in Couples with Unexplained Infertility Undergoing Mild Ovarian Stimulation and Intrauterine Insemination

    Not recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands

Glossary

  • Luteal Phase Support (LPS): The use of hormones, typically progesterone, to support the uterine lining after ovulation or during fertility treatments to improve the chances of embryo implantation and maintaining early pregnancy.
  • Intrauterine Insemination (IUI): A fertility treatment where sperm is placed directly into the uterus around the time of ovulation to increase the chances of fertilization.
  • In Vitro Fertilization (IVF): A complex series of procedures used to help with fertility or prevent genetic problems and assist with the conception of a child.
  • Frozen Embryo Transfer (FET): A type of IVF where a frozen embryo from a previous treatment cycle is thawed and transferred to the uterus.
  • Blastocyst: An embryo that has developed for five to seven days after fertilization and has a fluid-filled cavity and two distinct cell types.
  • Antral Follicle Count (AFC): A measure of the number of small follicles in the ovaries, used to assess ovarian reserve and predict response to fertility treatments.
  • Anti-Müllerian Hormone (AMH): A hormone produced by the ovaries that is used as a marker of ovarian reserve and to predict response to fertility treatments.
  • Gonadotropins: Hormones that stimulate the ovaries to produce eggs, often used in fertility treatments to induce ovulation.
  • Endometrial Receptivity: The state of the uterine lining when it is most receptive to embryo implantation, typically occurring during the luteal phase of the menstrual cycle.
  • Ovarian Stimulation: The use of medications to stimulate the ovaries to produce multiple eggs for fertility treatments.

References

  1. http://clinicaltrials.eu/trial/study-on-progesterone-for-improving-birth-rates-in-couples-with-unexplained-infertility-undergoing-mild-ovarian-stimulation-and-intrauterine-insemination/
  2. http://clinicaltrials.eu/trial/study-on-the-effectiveness-of-vaginal-micronized-progesterone-for-infertility-in-patients-undergoing-assisted-conception-with-frozen-embryo-transfer-ac-fet/